APRINOIA Therapeutics (APRI) – Analyst EPS View
-
Roth Capital Cuts Price Target on Apricus Biosciences (APRI) to $3 Following 2Q15
-
Roth Capital Cuts Price Target on Apricus Biosciences (APRI) to $3 Following 2Q15
-
-
-
Back to APRI Stock Lookup